Home
Live Updates
BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement : vimarsana.com
BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...
Related Keywords
Israel ,
China ,
Russia ,
Ukraine ,
United States ,
Russian ,
Gloria Biosciences ,
Philip Serlin ,
Moran Meir ,
John Lacey ,
Blackrock ,
Washington University School Of Medicine ,
Linkedin ,
Lifesci Advisors ,
Twitter ,
Biolinerx Ltd ,
Exchange Commission On ,
Columbia University ,
Prnewswire Biolinerx Ltd ,
Growth Lending ,
Kreos Capital ,
Chief Executive Officer ,
Washington University School ,
Panc Phase ,
Private Securities Litigation Reform Act ,
Exchange Commission ,
Sci Advisors ,
vimarsana.com © 2020. All Rights Reserved.